Acerus Drug Patent Portfolio

Acerus owns 1 orange book drug protected by 5 US patents Given below is the list of Acerus's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11090312 Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event 17 Mar, 2034
Active
US8574622 Controlled release delivery system for nasal applications 04 Feb, 2024 Expired
US8784869 Controlled release delivery system for nasal applications and methods of treatment 04 Feb, 2024 Expired
US8784882 Controlled release delivery system for nasal applications and method of treatment 04 Feb, 2024 Expired
US8877230 Controlled release delivery system for nasal applications 04 Feb, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Acerus.

Activity Date Patent Number
Patent litigations
Change in Power of Attorney (May Include Associate POA) 02 Jul, 2024 US11090312
Email Notification 02 Jul, 2024 US11090312
Email Notification 14 Apr, 2022 US8574622
Mail Certificate of Correction Memo 13 Apr, 2022 US8574622
Certificate of Correction Memo 07 Apr, 2022 US8574622
Payment of Maintenance Fee, 8th Yr, Small Entity 15 Feb, 2022 US8877230
Payment of Maintenance Fee, 8th Yr, Small Entity 12 Jan, 2022 US8784869
Recordation of Patent Grant Mailed 17 Aug, 2021 US11090312
Patent Issue Date Used in PTA Calculation 17 Aug, 2021 US11090312
Payment of Maintenance Fee, 8th Yr, Small Entity 12 Aug, 2021 US8784882
Email Notification 29 Jul, 2021 US11090312
Issue Notification Mailed 28 Jul, 2021 US11090312
Dispatch to FDC 13 Jul, 2021 US11090312
Workflow - Drawings Finished 09 Jul, 2021 US11090312
Mail PUB other miscellaneous communication to applicant 08 Jul, 2021 US11090312


Acerus's Family Patents

Acerus drugs have patent protection in a total of 22 countries. It has a significant patent presence in the US with 58.2% of its patents being US patents. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Acerus Drug List

Given below is the complete list of Acerus's drugs and the patents protecting them.


1. Natesto

Natesto is protected by 5 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11090312 Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event 17 Mar, 2034
(9 years from now)
Active
US8574622 Controlled release delivery system for nasal applications 04 Feb, 2024
(8 months ago)
Expired
US8784869 Controlled release delivery system for nasal applications and methods of treatment 04 Feb, 2024
(8 months ago)
Expired
US8784882 Controlled release delivery system for nasal applications and method of treatment 04 Feb, 2024
(8 months ago)
Expired
US8877230 Controlled release delivery system for nasal applications 04 Feb, 2024
(8 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Natesto's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List